Lozada, Reynerio A.
HRN: 10-30-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/05/2025
METRONIDAZOLE 500MG (TAB)
04/05/2025
04/12/2025
ORAL
500mg
Q8
Indirect Inguimal Hernia, Right Reducible
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes